Priming of NADPH oxidase by tumor necrosis factor alpha in patients with inflammatory and autoimmune rheumatic diseases.

Miesel, R; Hartung, R; Kroeger, H

Miesel, R; Hartung, R; Kroeger, H.

Affiliation

Miesel R; University of Otago, Department of Biochemistry Dunedin, New Zealand.

Inflammation ; 20(4): 427-38, 1996 Aug.

Article in En | MEDLINE | ID: mdl-8872505

Subject(s)

Autoimmune Diseases/blood; Connective Tissue Diseases/blood; Inflammation/blood; Monocytes/enzymology; NADPH Oxidases/blood; Neutrophils/enzymology; Reactive Oxygen Species/metabolism; Rheumatic Diseases/blood; Tumor Necrosis Factor-alpha/analysis; Acridines; Blood Sedimentation; C-Reactive Protein/analysis; Combined Modality Therapy; Female; Granulomatosis with Polyangiitis/blood; Granulomatosis with Polyangiitis/therapy; Humans; Luminescent Measurements; Male; NADPH Oxidases/metabolism; Oxidative Stress; Phagocytosis; Prednisolone/pharmacology; Prednisolone/therapeutic use; Renal Dialysis; Superoxides/metabolism; Tumor Necrosis Factor-alpha/physiology

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Autoimmune Diseases / Monocytes / Rheumatic Diseases / Tumor Necrosis Factor-alpha / Reactive Oxygen Species / Connective Tissue Diseases / NADPH Oxidases / Inflammation / Neutrophils Limits: Female / Humans / Male Language: En Journal: Inflammation Year: 1996 Document type: Article Affiliation country: New Zealand Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links